| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $162K | +3140.0% |
| R&D Expense | $5.7M | -6.4% |
| SG&A Expense | $13.4M | -6.4% |
| Operating Income | -$19.4M | +4.7% |
| Pre-tax Income | -$18.2M | -0.3% |
| Income Tax | -$2K | -166.7% |
| Net Income | -$18.2M | -0.3% |
| EPS (Basic) | -$5.00 | +1.0% |
| EPS (Diluted) | -$5.00 | +1.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $15.5M | -33.3% |
| Accounts Receivable | $19K | — |
| Current Assets | $21.7M | -43.3% |
| Total Assets | $31.1M | -37.4% |
| Current Liabilities | $2.0M | -71.9% |
| Total Liabilities | $8.6M | -14.0% |
| Stockholders' Equity | $22.5M | -43.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.6M | -2.1% |
| Capital Expenditures | $17K | -22.7% |
| Investing Cash Flow | $8.8M | -29.6% |
| Financing Cash Flow | -$873K | -576.7% |
| Free Cash Flow | -$15.7M | -2.0% |